对于神经疾病的微针介导药物输送
Shuna Tan1, Yitian Wang1, Xuan Wei1
1Laboratory of Molecular Translational Medicine, Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, PR China; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, PR China.
International journal of pharmaceutics
|July 1, 2024
概括
微针 (MNs) 提供了一个有希望的,无痛的通过皮肤输送系统,用于治疗神经系统疾病,如脑损伤和瘤. 这篇评论探讨了MN的进步及其对大脑疾病的治疗潜力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 神经科学是一个神经科学.
背景情况:
- 神经系统疾病是全球死亡的主要原因,需要新的治疗策略.
- 目前用于神经疾病的治疗方法在有效性和侵入性方面面临挑战.
- 通过皮肤递送药物为治疗大脑疾病提供了一个不那么侵入性的替代方案.
研究的目的:
- 审查微针 (MN) 在治疗神经疾病方面的进展和应用.
- 突出MNs作为无痛和非侵入性治疗输送系统的潜力.
- 讨论未来的趋势和挑战在神经应用的MNs的发展.
主要方法:
- 文献综述专注于微针技术及其在神经科学中的应用.
- 对研究MN的血液-大脑屏障传递药物的研究分析.
- 综合目前关于MN生物相容性,可持续性和治疗功效的研究.
主要成果:
- 微针显示出无痛和非侵入性通过皮肤递送治疗药物的巨大潜力.
- 与传统的药物输送方法相比,MNs提供了更好的生物相容性和可持续性.
- 新兴研究表明,MNs可以促进针对神经疾病的向药物输送.
结论:
- 微针在治疗神经系统疾病方面是一个有前途的进步.
- 需要进一步的研究和开发,以克服基于MN的神经治疗的挑战.
- MN技术有可能彻底改变脑损伤,瘤和神经退行性疾病的管理.
相关概念视频
Drug Delivery: Parenteral Route
480
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
480
Drug Delivery: Miscellaneous Routes
338
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
338


